Globavir Biosciences

Globavir Biosciences

A biopharmaceutical company creating novel therapeutics and diagnostic tool for treating infectious disease.

All edits by  Jason D. Rowley 

Edits on 3 Jul, 2020
Jason D. Rowley
Jason D. Rowley approved a suggestion from Golden's AI on 3 Jul, 2020
Edits made to:
Article (+21/-21 characters)

On January 21, 2015 Globavir Biosciences announced raising $4 million in venture funding from StartX, Stanford University Venture Fund, and Sorrento TherapeuticsSorrento Therapeutics.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.